Abstract
Many biomedical devices are powered and controlled by electrical components. These electronics add to the cost of a device (possibly making the device too expensive for use in resource-limited or point-of-care settings) and can also render the device unsuitable for use in some environments (for example, high-humidity areas like incubators where condensation could cause electrical short circuits, ovens where electronic components may overheat, or explosive or flammable environments where electric sparks could cause serious accidents). In this work, we show that pneumatic logic can be used to power and control biomedical devices without the need for electricity or electric components. Originally developed for controlling microfluidic “lab-on-a-chip” devices, these circuits use microfluidic valves like transistors in air-powered logic “circuits.” We show that a modification to the basic valve design—adding additional air channels in parallel through the valve—creates a “high-flow” valve that is suitable for controlling a broad range of bioinstruments, not just microfluidics. As a proof-of-concept, we developed a high-flow pneumatic oscillator that uses five high-flow Boolean NOT gates arranged in a loop. Powered by a single constant vacuum source, the oscillator provides five out-of-phase pneumatic outputs that switch between vacuum and atmospheric pressure every 1.3 seconds. Additionally, a user can adjust the frequency of the oscillator by squeezing a bellows attached to one of the pneumatic outputs. We then used the pneumatic oscillator to power a low-cost 3D-printed laboratory rocker/shaker commonly used to keep blood products, cell cultures, and other heterogenous samples in suspension. Our air-powered rocker costs around $5 USD to build and performs as well as conventional electronic rockers that cost $1000 USD or more. This is the first of many biomedical devices that can be made cheaper and safer using pneumatic logic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Science Foundation's Division of Civil, Mechanical and Manufacturing Innovation (CMMI) under award numbers 1740052 (Philip Brisk), 2046270 (Konstantinos Karydis), and 2133084 (Konstantinos Karydis), the National Science Foundation's Division of Computing and Communication Frontiers (CCF) under award number 2019362 (William H. Grover), and the National Science Foundation's Division of Biological Infrastructure (DBI) under award number 2131428 (William H. Grover).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Statements and Declarations The authors have no relevant financial or non-financial interests to disclose.
Data Availability
All data produced in the present work are contained in the manuscript.